In today’s recent session, 2.66 million shares of the Coherus Biosciences Inc (NASDAQ:CHRS) have been traded, and its beta is 0.86. Most recently the company’s share price was $1.78, and it changed around $0.08 or 5.00% from the last close, which brings the market valuation of the company to $231.53M. CHRS at last check was trading at a discount to its 52-week high of $3.70, offering almost -107.87% off that amount. The share price’s 52-week low was $0.66, which indicates that the recent value has risen by an impressive 62.92% since then. We note from Coherus Biosciences Inc’s average daily trading volume that its 10-day average is 16.68 million shares, with the 3-month average coming to 5.08 million.
Coherus Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.33. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended CHRS as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Coherus Biosciences Inc is expected to report earnings per share of -0.18 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Coherus Biosciences Inc (NASDAQ:CHRS) trade information
Instantly CHRS has been showing a green trend so far today with a performance of 5.00% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.4300 on recent trading dayincreased the stock’s daily price by 26.75%. The company’s shares are currently down -46.40% year-to-date, but still up 30.29% over the last five days. On the other hand, Coherus Biosciences Inc (NASDAQ:CHRS) is 117.68% up in the 30-day period. We can see from the shorts that 33.04 million shares have been sold at a short interest cover period of 12.34 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 70.33% from its current value. Analyst projections state that CHRS is forecast to be at a low of $6 and a high of $6.
Coherus Biosciences Inc (CHRS) estimates and forecasts
Coherus Biosciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 2.59 percent over the past six months and at a 64.65% annual growth rate that is well above the industry average of 17.10%. The year-over-year growth rate is expected to be -0.65%, down from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 43.88M in revenue for the current quarter. 1 analysts expect Coherus Biosciences Inc to make 60M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 91.52M and 77.06M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -52.06%. Forecasts for the next quarter put sales growth at -22.14%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 4.73%.
CHRS Dividends
Coherus Biosciences Inc’s next quarterly earnings report is expected to be released in January.
Coherus Biosciences Inc (NASDAQ:CHRS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.39% of Coherus Biosciences Inc shares, and 70.09% of them are in the hands of institutional investors. The stock currently has a share float of 71.08%. Coherus Biosciences Inc stock is held by 176.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 10.4236% of the shares, which is about 11.75 million shares worth $20.33 million.
VANGUARD GROUP INC, with 9.4035% or 10.6 million shares worth $18.34 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Sep 30, 2024. The former held 3.43 shares worth $6.08 million, making up 2.98% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 2.88 shares worth around $5.1 million, which represents about 2.50% of the total shares outstanding.
